Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04431700 · ClinicalTrials.gov registry record · NA
Study of Dietary Composition in Crohn's Disease
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04431700 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 28 participants.
The verdict
NCT04431700, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Patients with inflammatory bowel disease (IBD) often have narrowed microbial diversity and altered composition and function of the gut microbiome. We anticipate the anti-inflammatory diet, when compared with the usual diet, to produce favorable changes in these multi-omics profiles. These findings will provide insight into the interactions between diet and host biology, while providing clues on the mechanisms of diet therapy's effect and CD pathogenesis.
Interventions
- OTHER Anti-inflammatory diet
- OTHER Regular diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04431700
The ClinicalTrials.gov registry entry for NCT04431700 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anti-inflammatory diet is the first listed.
NCT04431700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04431700 about?
NCT04431700 is a clinical study titled "Study of Dietary Composition in Crohn's Disease". Patients with inflammatory bowel disease (IBD) often have narrowed microbial diversity and altered composition and function of the gut microbiome. We anticipate the anti-inflammatory diet, when compared with the usual diet, to produce favorable changes in these multi-omics profiles. These findings w...
What is the current status of trial NCT04431700?
This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2020-10-05. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04431700?
The interventions under investigation include: Anti-inflammatory diet (OTHER), Regular diet (OTHER).
Who is sponsoring clinical trial NCT04431700?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.